Surovik Jamie, Riddel Catherine, Chon Susan Y
University of Texas Health Science Center at Houston, 77030, USA.
J Drugs Dermatol. 2010 Aug;9(8):1010-2.
Bupropion is a very popular medication prescribed to millions of patients globally for depression (Wellbutrin, GlaxoSmithKline, Research Triangle Park, NC) as well as an aid in smoking cessation (Zyban, GlaxoSmithKline, Research Triangle Park, NC). It has been reported to have some common dermatologic side effects, such as pruritus, urticaria and serum-sickness like reaction. The authors report a case of bupropion-induced Stevens-Johnson syndrome (SJS) with a concomitant acute psoriatic exacerbation in a 56-year-old woman, who began taking bupropion for treatment of depression. While the United States (U.S.) prescribing information for bupropion does include SJS as a rare potential side effect, it does not mention worsening of psoriasis. Physicians should be aware of the potential life-threatening adverse effects of this commonly prescribed medication as well as the risk in patients with known psoriasis.
安非他酮是一种非常受欢迎的药物,在全球范围内有数百万患者因抑郁症(安非他酮,葛兰素史克公司,北卡罗来纳州三角研究园)以及辅助戒烟(载班,葛兰素史克公司,北卡罗来纳州三角研究园)而服用。据报道,它有一些常见的皮肤副作用,如瘙痒、荨麻疹和血清病样反应。作者报告了一例56岁女性因服用安非他酮治疗抑郁症而引发史蒂文斯-约翰逊综合征(SJS)并伴有急性银屑病加重的病例。虽然美国安非他酮的处方信息确实将SJS列为罕见的潜在副作用,但并未提及银屑病病情恶化。医生应该意识到这种常用药物潜在的危及生命的不良反应以及已知患有银屑病患者的风险。